+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
Common Warts - Epidemiology Forecast - 2032 - Product Thumbnail Image

Common Warts - Epidemiology Forecast - 2032

  • Report
  • July 2022
  • 92 Pages
  • Global
From
From
Burns - Epidemiology Forecast - 2032 - Product Thumbnail Image

Burns - Epidemiology Forecast - 2032

  • Report
  • July 2022
  • 113 Pages
  • Global
From
From
Contact Dermatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Contact Dermatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Inducible Urticaria Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inducible Urticaria Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Prurigo Nodularis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Prurigo Nodularis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Radiation Dermatitis - Epidemiology Insight - 2032 - Product Thumbnail Image

Radiation Dermatitis - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Netherton Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Netherton Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Bullous Pemphigoid - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bullous Pemphigoid - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more